Ledyard National Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,212
Closed -$210K 241
2025
Q4
$210K Sell
1,212
-9
-0.7% -$1.64K 0.02% 233
2025
Q3
$233K Sell
1,221
-164
-12% -$29.1K 0.02% 209
2025
Q2
$249K Buy
1,385
+9
+0.7% +$1.56K 0.02% 196
2025
Q1
$233K Sell
1,376
-3
-0.2% -$493 0.02% 200
2024
Q4
$208K Buy
+1,379
New +$214K 0.02% 208
2024
Q3
Sell
-1,878
Closed -$257K 222
2024
Q2
$257K Buy
1,878
+4
+0.2% +$548 0.03% 190
2024
Q1
$249K Hold
1,874
0.02% 197
2023
Q4
$258K Buy
+1,874
New +$246K 0.03% 186
2019
Q1
Sell
-1,100
Closed -$92K 352
2018
Q4
$92K Buy
1,100
+500
+83% +$46.9K 0.01% 344
2018
Q3
$65K Hold
600
0.01% 397
2018
Q2
$66K Hold
600
0.01% 396
2018
Q1
$60K Hold
600
0.01% 421
2017
Q4
$59K Hold
600
0.01% 436
2017
Q3
$56K Buy
+600
New +$63.7K 0.01% 433
2015
Q3
Sell
-92
Closed -$7K 678
2015
Q2
$7K Hold
92
﹤0.01% 558
2015
Q1
$7K Buy
+92
New +$6.59K ﹤0.01% 537
2014
Q4
Sell
-40
Closed -$2K 728
2014
Q3
$2K Sell
40
-84
-68% -$5.18K ﹤0.01% 667
2014
Q2
$7K Hold
124
﹤0.01% 535
2014
Q1
$7K Buy
+124
New +$6.65K ﹤0.01% 511

Other funds holding DGX

Ledyard National Bank's DGX Position: Q1 2026 in Review

Ledyard National Bank sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,212 shares — an estimated $210K sold.

Ledyard National Bank first reported a position in DGX in Q1 2014 and held it in 19 quarters. The position peaked at $258K in Q4 2023. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Ledyard National Bank reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Ledyard National Bank sold 1,212 Quest Diagnostics shares in Q1 2026, an estimated $210K.
  • Ledyard National Bank first reported a position in Quest Diagnostics in Q1 2014 and held it in 19 quarters.
  • Ledyard National Bank's Quest Diagnostics position peaked at $258K in Q4 2023.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Ledyard National Bank's 13F filing for Q1 2026, filed 24 Apr 2026.